Vandetanib versus Cabozantinib in Medullary Thyroid Carcinoma: A Focus on Anti-Angiogenic Effects in Zebrafish Model

Medullary thyroid carcinoma (MTC) is a tumor deriving from the thyroid C cells. Vandetanib (VAN) and cabozantinib (CAB) are two tyrosine kinase inhibitors targeting REarranged during Transfection (RET) and other kinase receptors and are approved for the treatment of advanced MTC. We aim to compare t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Mol Sci
Main Authors: Carra, Silvia, Gaudenzi, Germano, Dicitore, Alessandra, Saronni, Davide, Cantone, Maria Celeste, Plebani, Alice, Ghilardi, Anna, Borghi, Maria Orietta, Hofland, Leo J., Persani, Luca, Vitale, Giovanni
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8002338/
https://ncbi.nlm.nih.gov/pubmed/33809722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms22063031
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados